We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSKE
4726
DELISTED
Daseke, Inc. Common Stock
DSKE
$568K ﹤0.01%
179,858
+23,468
+15% +$68.7K
BSRR icon
4727
Sierra Bancorp
BSRR
$525M
$567K ﹤0.01%
19,477
+6,119
+46% +$168K
MOFG
4728
DELISTED
MidWestOne Financial Group
MOFG
$567K ﹤0.01%
15,662
+6,128
+64% +$205K
PLAN
4729
CALL
DELISTED
Anaplan, Inc.
PLAN
$566K ﹤0.01%
10,800
-224,200
-95% -$11.1M
UPH
4730
DELISTED
UpHealth, Inc.
UPH
$564K ﹤0.01%
+5,670
New +$560K
TRC icon
4731
Tejon Ranch
TRC
$447M
$563K ﹤0.01%
35,249
+501
+1% +$8.18K
OI icon
4732
O-I Glass
OI
$1.1B
$562K ﹤0.01%
47,095
+33,353
+243% +$333K
UI icon
4733
Ubiquiti
UI
$34.7B
$562K ﹤0.01%
2,974
-2,325
-44% -$375K
I
4734
PUT
DELISTED
INTELSAT S. A.
I
$562K ﹤0.01%
80,000
+33,900
+74% +$533K
WAAS
4735
DELISTED
AquaVenture Holdings Limited
WAAS
$562K ﹤0.01%
20,725
+3,248
+19% +$68.9K
TELL
4736
CALL
DELISTED
Tellurian Inc.
TELL
$561K ﹤0.01%
77,000
-120,000
-61% -$913K
SRNE
4737
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$560K ﹤0.01%
165,663
+64,030
+63% +$153K
ARCO icon
4738
Arcos Dorados Holdings
ARCO
$1.67B
$559K ﹤0.01%
70,829
+2,208
+3% +$15.9K
APEI icon
4739
American Public Education
APEI
$839M
$558K ﹤0.01%
20,386
+8,231
+68% +$201K
CARG icon
4740
CarGurus
CARG
$3.22B
$558K ﹤0.01%
+15,857
New +$561K
AMNB
4741
DELISTED
American National Bankshares Inc
AMNB
$558K ﹤0.01%
14,093
+5,942
+73% +$221K
CCRN
4742
DELISTED
Cross Country Healthcare
CCRN
$557K ﹤0.01%
47,854
+16,282
+52% +$184K
GSHD icon
4743
Goosehead Insurance
GSHD
$2.32B
$557K ﹤0.01%
13,137
+9,246
+238% +$409K
NOK icon
4744
CALL
Nokia
NOK
$52.7B
$557K ﹤0.01%
150,000
CDMO
4745
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$557K ﹤0.01%
72,580
+37,927
+109% +$221K
GOGO icon
4746
Gogo Inc
GOGO
$392M
$556K ﹤0.01%
86,985
+12,362
+17% +$72K
PPC icon
4747
Pilgrim's Pride
PPC
$6.4B
$556K ﹤0.01%
16,995
-15,788
-48% -$491K
VIVO
4748
DELISTED
Meridian Bioscience Inc
VIVO
$556K ﹤0.01%
56,966
+18,448
+48% +$173K
ODT
4749
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$555K ﹤0.01%
17,100
+6,915
+68% +$214K
PCQ
4750
Pimco California Municipal Income Fund
PCQ
$168M
$553K ﹤0.01%
27,853
+268
+1% +$5.37K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.